The final diagnosis of SFT is based on the immunohistochemical detection of a fusion between NAB2::STAT6 genes, in practice by using STAT6 immunochemical stain (1, 2) (Figure 2). This evidence concerns the gene STAT6 and solitary fibrous tumor.